Clinical outcomes and cardiac safety of continuous antiHer2 therapy in c-erbB2-positive metastatic breast cancer patients
- Author
- FEDELE, Palma1 ; ORLANDO, Laura1 ; RIZZO, Pietro1 ; LORUSSO, Vito3 ; CINIERI, Saverio1 4 ; SCHIAVONE, Paola1 ; CICCARESE, Mariangela2 ; FORCIGNANO, Rosa Chiara2 ; CALVANI, Nicola1 ; MARINO, Antonella1 ; NACCI, Angelo1 ; SPONZIELLO, Francesco1 ; MAZZONI, Enrica1
[1] Medical Oncology & Breast Unit, 'A. Perrino' Hospital, Brindisi, Italy
[2] Medical Oncology, 'V. Fazzi' Hospital, Lecce, Italy
[3] Division of Medical Oncology, IRCCS, Giovanni Paolo II Hospital, Bari, Italy
[4] Department of Medicine, European Institute of Oncology, Milan, Italy - Source
Journal of chemotherapy (Testo stampato). 2013, Vol 25, Num 6, pp 369-375, 7 p ; ref : 50 ref
- ISSN
- 1120-009X
- Scientific domain
- Pharmacology drugs
- Publisher
- EIFT, Firenze
- Publication country
- Italy
- Document type
- Article
- Language
- English
- Author keyword
- Cardiac safety Lapatinib Metastatic breast cancer Overall survival Trastuzumab
- Keyword (fr)
- Anticancéreux Cancer du sein Coeur En continu Gène erbB2 Gène onc cellulaire Homme Immunomodulateur Lapatinib Malade Métastase Métastatique Pronostic Stade avancé Survie Sécurité Toxicité Traitement Trastuzumab Anti-HER2 Anticorps monoclonal Cancer Enzyme Inhibiteur de la tyrosine kinase Inhibiteur enzyme Pathologie de la glande mammaire Pathologie du sein Protein-tyrosine kinase Transferases Tumeur maligne
- Keyword (en)
- Antineoplastic agent Breast cancer Heart Continuous process erbB2 Gene C-Onc gene Human Immunomodulator Lapatinib Patient Metastasis Metastatic Prognosis Advanced stage Survival Safety Toxicity Treatment Trastuzumab Monoclonal antibody Cancer Enzyme Tyrosine kinase inhibitor Enzyme inhibitor Mammary gland diseases Breast disease Protein-tyrosine kinase Transferases Malignant tumor
- Keyword (es)
- Anticanceroso Cáncer del pecho Corazón En continuo Gen erbB2 Gen onc celular Hombre Inmunomodulador Lapatinib Enfermo Metástasis Metastásico Pronóstico Estadio avanzado Sobrevivencia Seguridad Toxicidad Tratamiento Trastuzumab Anticuerpo monoclonal Cáncer Enzima Inhibidor tyrosine kinase Inhibidor enzima Glándula mamaria patología Seno patología Protein-tyrosine kinase Transferases Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors / 002B04C Multiple tumors. Solid tumors. Tumors in childhood (general aspects)
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20E Mammary gland diseases / 002B20E02 Tumors
- Discipline
- Gynecology. Andrology. Obstetrics Pharmacological treatments Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 28083821
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1179/1973947813Y.0000000098 
https://dx.doi.org/10.1179/1973947813Y.0000000098
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:30:\"10.1179\/1973947813Y.0000000098\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:121:\"Clinical outcomes and cardiac safety of continuous antiHer2 therapy in c-erbB2-positive metastatic breast cancer patients\";s:9:\"\u0000*\u0000jtitle\";s:40:\"Journal of chemotherapy (Testo stampato)\";s:9:\"\u0000*\u0000stitle\";s:28:\"J. chemother. (Testo stamp.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"369\";s:8:\"\u0000*\u0000epage\";s:3:\"375\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1120-009X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"FEDELE\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Palma\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"ORLANDO, Laura\";i:1;s:13:\"RIZZO, Pietro\";i:2;s:13:\"LORUSSO, Vito\";i:3;s:16:\"CINIERI, Saverio\";i:4;s:16:\"SCHIAVONE, Paola\";i:5;s:21:\"CICCARESE, Mariangela\";i:6;s:23:\"FORCIGNANO, Rosa Chiara\";i:7;s:15:\"CALVANI, Nicola\";i:8;s:17:\"MARINO, Antonella\";i:9;s:13:\"NACCI, Angelo\";i:10;s:21:\"SPONZIELLO, Francesco\";i:11;s:15:\"MAZZONI, Enrica\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:121:\"Clinical outcomes and cardiac safety of continuous antiHer2 therapy in c-erbB2-positive metastatic breast cancer patients\";s:8:\"\u0000*\u0000place\";s:7:\"Firenze\";s:6:\"\u0000*\u0000pub\";s:4:\"EIFT\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:30:\"10.1179\/1973947813Y.0000000098\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:121:\"Clinical outcomes and cardiac safety of continuous antiHer2 therapy in c-erbB2-positive metastatic breast cancer patients\";s:9:\"\u0000*\u0000jtitle\";s:40:\"Journal of chemotherapy (Testo stampato)\";s:9:\"\u0000*\u0000stitle\";s:28:\"J. chemother. (Testo stamp.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"369\";s:8:\"\u0000*\u0000epage\";s:3:\"375\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1120-009X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"FEDELE\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Palma\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"ORLANDO, Laura\";i:1;s:13:\"RIZZO, Pietro\";i:2;s:13:\"LORUSSO, Vito\";i:3;s:16:\"CINIERI, Saverio\";i:4;s:16:\"SCHIAVONE, Paola\";i:5;s:21:\"CICCARESE, Mariangela\";i:6;s:23:\"FORCIGNANO, Rosa Chiara\";i:7;s:15:\"CALVANI, Nicola\";i:8;s:17:\"MARINO, Antonella\";i:9;s:13:\"NACCI, Angelo\";i:10;s:21:\"SPONZIELLO, Francesco\";i:11;s:15:\"MAZZONI, Enrica\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:121:\"Clinical outcomes and cardiac safety of continuous antiHer2 therapy in c-erbB2-positive metastatic breast cancer patients\";s:8:\"\u0000*\u0000place\";s:7:\"Firenze\";s:6:\"\u0000*\u0000pub\";s:4:\"EIFT\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:30:\"10.1179\/1973947813Y.0000000098\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:30:\"10.1179\/1973947813Y.0000000098\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:121:\"Clinical outcomes and cardiac safety of continuous antiHer2 therapy in c-erbB2-positive metastatic breast cancer patients\";s:9:\"\u0000*\u0000jtitle\";s:40:\"Journal of chemotherapy (Testo stampato)\";s:9:\"\u0000*\u0000stitle\";s:28:\"J. chemother. (Testo stamp.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"369\";s:8:\"\u0000*\u0000epage\";s:3:\"375\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1120-009X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"FEDELE\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Palma\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"ORLANDO, Laura\";i:1;s:13:\"RIZZO, Pietro\";i:2;s:13:\"LORUSSO, Vito\";i:3;s:16:\"CINIERI, Saverio\";i:4;s:16:\"SCHIAVONE, Paola\";i:5;s:21:\"CICCARESE, Mariangela\";i:6;s:23:\"FORCIGNANO, Rosa Chiara\";i:7;s:15:\"CALVANI, Nicola\";i:8;s:17:\"MARINO, Antonella\";i:9;s:13:\"NACCI, Angelo\";i:10;s:21:\"SPONZIELLO, Francesco\";i:11;s:15:\"MAZZONI, Enrica\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:121:\"Clinical outcomes and cardiac safety of continuous antiHer2 therapy in c-erbB2-positive metastatic breast cancer patients\";s:8:\"\u0000*\u0000place\";s:7:\"Firenze\";s:6:\"\u0000*\u0000pub\";s:4:\"EIFT\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:30:\"10.1179\/1973947813Y.0000000098\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:121:\"Clinical outcomes and cardiac safety of continuous antiHer2 therapy in c-erbB2-positive metastatic breast cancer patients\";s:9:\"\u0000*\u0000jtitle\";s:40:\"Journal of chemotherapy (Testo stampato)\";s:9:\"\u0000*\u0000stitle\";s:28:\"J. chemother. (Testo stamp.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"369\";s:8:\"\u0000*\u0000epage\";s:3:\"375\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1120-009X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"FEDELE\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Palma\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"ORLANDO, Laura\";i:1;s:13:\"RIZZO, Pietro\";i:2;s:13:\"LORUSSO, Vito\";i:3;s:16:\"CINIERI, Saverio\";i:4;s:16:\"SCHIAVONE, Paola\";i:5;s:21:\"CICCARESE, Mariangela\";i:6;s:23:\"FORCIGNANO, Rosa Chiara\";i:7;s:15:\"CALVANI, Nicola\";i:8;s:17:\"MARINO, Antonella\";i:9;s:13:\"NACCI, Angelo\";i:10;s:21:\"SPONZIELLO, Francesco\";i:11;s:15:\"MAZZONI, Enrica\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:121:\"Clinical outcomes and cardiac safety of continuous antiHer2 therapy in c-erbB2-positive metastatic breast cancer patients\";s:8:\"\u0000*\u0000place\";s:7:\"Firenze\";s:6:\"\u0000*\u0000pub\";s:4:\"EIFT\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:30:\"10.1179\/1973947813Y.0000000098\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:121:\"Clinical outcomes and cardiac safety of continuous antiHer2 therapy in c-erbB2-positive metastatic breast cancer patients\";s:9:\"\u0000*\u0000jtitle\";s:40:\"Journal of chemotherapy (Testo stampato)\";s:9:\"\u0000*\u0000stitle\";s:28:\"J. chemother. (Testo stamp.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"25\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"369\";s:8:\"\u0000*\u0000epage\";s:3:\"375\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1120-009X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"FEDELE\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Palma\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"ORLANDO, Laura\";i:1;s:13:\"RIZZO, Pietro\";i:2;s:13:\"LORUSSO, Vito\";i:3;s:16:\"CINIERI, Saverio\";i:4;s:16:\"SCHIAVONE, Paola\";i:5;s:21:\"CICCARESE, Mariangela\";i:6;s:23:\"FORCIGNANO, Rosa Chiara\";i:7;s:15:\"CALVANI, Nicola\";i:8;s:17:\"MARINO, Antonella\";i:9;s:13:\"NACCI, Angelo\";i:10;s:21:\"SPONZIELLO, Francesco\";i:11;s:15:\"MAZZONI, Enrica\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:121:\"Clinical outcomes and cardiac safety of continuous antiHer2 therapy in c-erbB2-positive metastatic breast cancer patients\";s:8:\"\u0000*\u0000place\";s:7:\"Firenze\";s:6:\"\u0000*\u0000pub\";s:4:\"EIFT\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
